
Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2025, titled "US FDA Inspection at Company s Bioequivalence Center located at Taloja".
Filed with NSE ·

Alkem Laboratories Limited has informed the Exchange regarding a press release dated March 13, 2025, titled "US FDA Inspection at Company s Bioequivalence Center located at Taloja".
6ix hasn’t read this filing yet.
Alkem Laboratories Ltd. on 6ix
Follow Alkem Laboratories into a list and get an email when it puts out news.
Follow Alkem Laboratories